Puma Biotechnology Inc ( PBYI )
Recent earnings result
- Puma Biotechnology EPS beats by $0.33, misses on revenue
- Puma Bio down 12% after hours as Nerlynx sales growth decelerates
Events & Annual meetings
Title | Date | Webcast |
---|---|---|
Jefferies 2019 Global Healthcare Conference | June 6, 2019 3:30 p.m. EDT | webcast |
Bank of America Merrill Lynch Health Care Conference 2019 | May 15, 2019 3:00 p.m. PDT | webcast |
Society of Gynecologic Oncology (SGO) 2019 Annual Meeting | March 16-19, 2019 |
|
Cowen and Company 39th Annual Health Care Conference | March 12, 2019 10:00 a.m. EDT | webcast |
Guggenheim Healthcare Talks Idea Forum | Oncology Day | February 14, 2019 | |
J. P. Morgan 37th Annual Healthcare Conference | January 9, 2019 12:00 Noon PST | |
Puma Biotechnology 1Q-2019 Financial Results Conference Call | May 9, 2019 1:30 p.m. PDT/4:30 p.m. EDT |
webcast
|
ASCO 2019 Annual Meeting | May 31 – June 4, 2019 |
|
AACR Annual Meeting 2019 | March 29 – April 3, 2019 | |
Puma Biotechnology 4Q-2018 Financial Results Conference Call | February 28, 2019 1:30 p.m. PST/4:30 p.m. EST |
webcast
|
Disclaimer:
For more information you may also visit their official Investor Relations website.
The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.
We focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.